Nebenwirkungen · Bondronat
Bondronat 2 mg concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 7
HOS-085643 · Präparat HOS-083171
System Organ Common Uncommon Rare Very rare Not known Class Infections and Infection Cystitis, vaginitis, infestations oral candidiasis Neoplasms Benign skin benign, neoplasm malignant and unspecified Blood and Anaemia, blood lymphatic dyscrasia system disorders Immune system Hypersensitivit Asthma disorders y†, exacerbation bronchospasm† , angioedema†, anaphylactic reaction/shock† ** Endocrine Parathyroid disorders disorder Metabolism and Hypocalcaemia** Hypophosphataemia nutrition disorders Psychiatric Sleep disorder, disorders anxiety, affection lability Nervous system Headache, Cerebrovascular disorders dizziness, disorder, nerve root dysgeusia (taste lesion, amnesia, perversion) migraine, neuralgia, hypertonia, hyperaestesia, paraesthesia circumoral, parosmia Eye disorders Cataract Ocular inflammation†** Ear and Deafness labyrinth disorders Cardiac Bundle branch Myocardial disorders block ischaemia, cardiovascular disorder, palpitations Respiratory, Pharyngitis Lung oedema, thoracic, and stridor mediastinal disorders
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-04-08T17:34:00Z · SHA-256 05636f81465a8a67f982eee4655be333acd7e9f5a20c04764f8127645519a0a1 · Passage ff3289b63e74d07317dedc6ea52843058f197f1dd6be448033ccca5771bf33e2 · Zeichen 1720–4083 im Abschnitt